Teva Pharms Drug Patent Portfolio
Teva Pharms owns 1 orange book drug protected by 1 US patent Given below is the list of Teva Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7456207 | Vaginal pharmaceutical compositions and methods for preparing them | 22 Sep, 2024 | Expired |
Latest Legal Activities on Teva Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Teva Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 23 Dec, 2016 | US7456207 |
|
Recordation of Patent Grant Mailed
Critical
| 25 Nov, 2008 | US7456207 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 25 Nov, 2008 | US7456207 |
|
Issue Notification Mailed
Critical
| 05 Nov, 2008 | US7456207 |
| Dispatch to FDC | 24 Oct, 2008 | US7456207 |
|
Application Is Considered Ready for Issue
Critical
| 17 Oct, 2008 | US7456207 |
|
Issue Fee Payment Verified
Critical
| 09 Oct, 2008 | US7456207 |
|
Issue Fee Payment Received
Critical
| 09 Oct, 2008 | US7456207 |
|
Mail Notice of Allowance
Critical
| 22 Sep, 2008 | US7456207 |
| Mail Examiner's Amendment | 22 Sep, 2008 | US7456207 |
|
Notice of Allowance Data Verification Completed
Critical
| 18 Sep, 2008 | US7456207 |
|
Case Docketed to Examiner in GAU
Critical
| 18 Sep, 2008 | US7456207 |
| Date Forwarded to Examiner | 14 Aug, 2008 | US7456207 |
| Response after Final Action | 04 Aug, 2008 | US7456207 |
| Mail Examiner Interview Summary (PTOL - 413) | 15 Jul, 2008 | US7456207 |
Teva Pharms's Family Patents
Recent FDA approvals and tentative approvals for Teva Pharms
This section lists recent FDA approvals and tentative approvals for Lupin, covering innovator and generic drugs with key regulatory details and timelines.
Generic drugs
Includes generic drug submissions with tentative FDA approvals, not yet marketable due to patent or exclusivity restrictions.
| Drug Name | Submission class (FDA) | Submission Category | Submission Date |
|---|---|---|---|
| Sheur |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | - | 22 Sep, 2025 |
| Nintedanib |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | - | 15 Aug, 2025 |
| Azacitidine |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | - | 10 Apr, 2025 |
Teva Pharms Drug List
Given below is the complete list of Teva Pharms's drugs and the patents protecting them.
1. Vandazole
Vandazole is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7456207 | Vaginal pharmaceutical compositions and methods for preparing them |
22 Sep, 2024
(1 year, 3 months ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Vandazole's drug page